1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 In Vitro Diagnostics (IVD) Market- Key Findings, 2020

3. Strategic Imperatives on Global In Vitro Diagnostics (IVD) Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key In Vitro Diagnostics (IVD) Companies

4. Global In Vitro Diagnostics (IVD) Market Value Outlook to 2026 Outlook by Technique

• 4.1 Histochemistry
• 4.2 Molecular Diagnostics
• 4.3 Hematology
• 4.4 POC Testing
• 4.5 Self-blood Glucose Testing
• 4.6 Immunochemistry
• 4.7 Other Techniques

5. Global In Vitro Diagnostics (IVD) Market Value Outlook to 2026 Outlook by Product

• 5.1 Instrument
• 5.2 Reagent
• 5.3 Others

6. Global In Vitro Diagnostics (IVD) Market Value Outlook to 2026 Outlook by Application

• 6.1 Infectious Disease
• 6.2 Diabetes
• 6.3 Cancer/Oncology
• 6.4 Cardiology
• 6.5 Autoimmune Disease
• 6.6 Nephrology
• 6.7 Drug Testing
• 6.8 Others

7. Global In Vitro Diagnostics (IVD) Market Value Outlook to 2026 Outlook by End Users

• 7.1 Hospitals
• 7.2 Laboratories
• 7.3 Home Care
• 7.4 Others

8 Asia Pacific In Vitro Diagnostics (IVD) Market Value Outlook to 2026

• 8.1 Leading In Vitro Diagnostics (IVD) Types contributing to Asia Pacific market
• 8.2 Top Applications contributing to Asia Pacific In Vitro Diagnostics (IVD)
• 8.3 Top countries contributing to Asia Pacific In Vitro Diagnostics (IVD)

9 Europe In Vitro Diagnostics (IVD) Market Value Outlook to 2026

• 9.1 Leading In Vitro Diagnostics (IVD) Types contributing to Europe market
• 9.2 Top Applications contributing to Europe In Vitro Diagnostics (IVD)
• 9.3 Top countries contributing to Europe In Vitro Diagnostics (IVD)

10 North America In Vitro Diagnostics (IVD) Market Value Outlook to 2026

• 10.1 Leading In Vitro Diagnostics (IVD) Types contributing to North America market
• 10.2 Top Applications contributing to North America In Vitro Diagnostics (IVD)
• 10.3 Top countries contributing to North America In Vitro Diagnostics (IVD)

11 South and Central America In Vitro Diagnostics (IVD) Market Value Outlook to 2026

• 11.1 Leading In Vitro Diagnostics (IVD) Types contributing to South and Central America market
• 11.2 Top Applications contributing to South and Central America In Vitro Diagnostics (IVD)
• 11.3 Top countries contributing to South and Central America In Vitro Diagnostics (IVD)

12 Middle East Africa In Vitro Diagnostics (IVD) Market Value Outlook to 2026

• 12.1 Leading In Vitro Diagnostics (IVD) Types contributing to Middle East Africa market
• 12.2 Top Applications contributing to Middle East Africa In Vitro Diagnostics (IVD)
• 12.3 Top countries contributing to Middle East Africa In Vitro Diagnostics (IVD)

13 Business Profiles of Leading Companies

• 13.1 Business Description, SWOT and Financial Analysis of Companies in In Vitro Diagnostics (IVD) market
• 13.2 Abbott Laboratories
• 13.3 Agilent Technologies
• 13.4 Arkray Inc.
• 13.5 Becton, Dickinson and Company
• 13.6 BioMerieux
• 13.7 Bio-Rad Laboratories, Inc.
• 13.8 Danaher Corporation
• 13.9 Diasorin
• 13.10 F. Hoffmann-La Roche AG
• 13.11 Johnson & Johnson

14 Recent Industry Developments

15 Appendix

• 15.1 OGAnalysis Expertise
• 15.2 Sources and Methodology

The study predicts the short term and long term trends that can shape up the future of the In Vitro Diagnostics (IVD) market including the COVID-19 pandemic implications for In Vitro Diagnostics (IVD)s industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The In Vitro Diagnostics (IVD) market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. In Vitro Diagnostics (IVD) Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. In Vitro Diagnostics (IVD) market forecast and In Vitro Diagnostics (IVD) market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the In Vitro Diagnostics (IVD) market opportunities, underlying market factors, demographic and economic factors, market developments and others.

In Vitro Diagnostics (IVD) industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening In Vitro Diagnostics (IVD) market share in developed countries.

Scope of the research-

Global In Vitro Diagnostics (IVD) Market is analyzed and forecast over the outlook period from 2020 to 2026 By technique including
Histochemistry
Molecular Diagnostics
Hematology
POC Testing
Self-blood Glucose Testing
Immunochemistry
Other Techniques

Global In Vitro Diagnostics (IVD) Market is analyzed and forecast over the outlook period from 2020 to 2026 By Product including
Instrument
Reagent
Others

Global In Vitro Diagnostics (IVD) Market is analyzed and forecast over the outlook period from 2020 to 2026 By application including
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Drug Testing
Others

Global In Vitro Diagnostics (IVD) Market is analyzed and forecast over the outlook period from 2020 to 2026 By End User includings
Hospitals
Laboratories
Home Care
Others

Top Companies Operating in In Vitro Diagnostics (IVD) market include- Abbott Laboratories , Agilent Technologies  , Arkray Inc. , Becton, Dickinson and Company , BioMerieux , Bio-Rad Laboratories, Inc. , Danaher Corporation , Diasorin  , 130 F. Hoffmann-La Roche AG , 131 Johnson & Johnson